| Recruiting | Effect of Video Viewing on Intravitreal Injection Experience NCT07002372 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Unknown | Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases NCT05337332 | Benha University | Phase 2 / Phase 3 |
| Completed | Cool vs Room-temperature Artificial Tears NCT05832996 | University of Iowa | Phase 4 |
| Terminated | Effectiveness of Periocular Drug Injection in CATaract Surgery NCT05158699 | Luigi Rondas | Phase 3 |
| Unknown | Cystoid Macular Edema After Vitrectomy for Rhegmatogenous Retinal Detachment NCT05069675 | University of Catania | — |
| Unknown | Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS NCT04856670 | Uptown Eye Specialists | — |
| Recruiting | Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema NCT04225611 | Massachusetts Eye and Ear Infirmary | Phase 1 / Phase 2 |
| Completed | The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections NCT05615805 | University of Oklahoma | N/A |
| Terminated | Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet NCT04527523 | Wake Forest University Health Sciences | — |
| Unknown | Minocycline Treatment for Cystoid Macular Edema NCT05474950 | Sun Yat-sen University | Phase 1 / Phase 2 |
| Unknown | Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery NCT03465124 | Medical University of Vienna | N/A |
| Completed | Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser NCT04234438 | Ankara Universitesi Teknokent | N/A |
| Withdrawn | Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid M NCT02598869 | Oregon Health and Science University | Phase 4 |
| Completed | Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema NCT02609165 | Ospedale San Raffaele | Phase 2 |
| Completed | Variable Interval Versus Set Interval Aflibercept for DME NCT02392364 | California Retina Consultants | Phase 4 |
| Unknown | Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection NCT02486484 | Rafic Hariri University Hospital | Phase 2 |
| Unknown | Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective Study NCT02804360 | Rafic Hariri University Hospital | Phase 2 |
| Completed | Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Aceton NCT02294656 | Soll Eye | Phase 1 |
| Terminated | Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma NCT01471054 | Arman Mashayekhi | Phase 2 |
| Completed | Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo NCT03025945 | Intuor Technologies, Inc. | N/A |
| Completed | Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification NCT02084576 | Hospital Oftalmologico de Brasilia | Phase 4 |
| Completed | PRevention of Macular EDema After Cataract Surgery NCT01774474 | Maastricht University Medical Center | Phase 3 |
| Completed | Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudo NCT01978015 | University of Campinas, Brazil | Phase 4 |
| Completed | Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema NCT00790803 | Wake Forest University | N/A |
| Withdrawn | Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative NCT00438243 | Johns Hopkins University | Phase 2 |
| Completed | Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a NCT00508040 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery NCT00494494 | University of North Carolina, Chapel Hill | Phase 4 |
| Completed | Lucentis for Treatment of Macular Edema NCT00464581 | Retina Institute of Hawaii | — |
| Completed | Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of C NCT00469781 | Center For Excellence In Eye Care | Phase 4 |
| Withdrawn | Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME) NCT00406172 | Asociación para Evitar la Ceguera en México | Phase 3 |
| Terminated | The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema NCT00358423 | Johns Hopkins University | Phase 1 / Phase 2 |
| Terminated | Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics NCT00346983 | Johns Hopkins University | Phase 1 / Phase 2 |
| Terminated | Study to Treat Uveitis Associated Macular Edema NCT00114062 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Vitamin E to Treat Uveitis-Associated Macular Edema NCT00021645 | National Eye Institute (NEI) | Phase 1 |
| Unknown | The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uvei NCT00893854 | Shahid Beheshti University of Medical Sciences | Phase 1 |